EventHealthJuly 15, 2026

OpenAI researcher Miles Wang in talks to launch AI drug discovery startup at $2B valuation

Read original source →techcrunch.com

Lightspeed is in discussions to lead the funding round for the venture, which would focus on AI-driven drug discovery. Wang is a researcher at OpenAI known for contributions to language models.

People · Miles Wang

1 source

More stories today

Open the live feed